
Licensing opportunities
Tyrosinase: New Enzyme for Crosslinking of Proteins
VTT has developed a method where it is possible to crosslink proteins without mediators by attacking the protein directly through tyrosyl residue oxidation.
Read more
Case studies

VTT Ventures sells its shares of Awanic Oy to Nordic Healthcare Group
Read more
Insights

VTT is hiring entrepreneurs
Read more
